Structure-based virtual screening for ligands of G protein–coupled receptors: what can molecular docking do for you?

F Ballante, AJ Kooistra, S Kampen, C de Graaf… - Pharmacological …, 2021 - Elsevier
G protein–coupled receptors (GPCRs) constitute the largest family of membrane proteins in
the human genome and are important therapeutic targets. During the last decade, the …

Molecular dynamics-driven drug discovery: leaping forward with confidence

A Ganesan, ML Coote, K Barakat - Drug discovery today, 2017 - Elsevier
Highlights•Currently, developing a market-approved drug costs a staggering $2.6 billion.•In
silico methods have become an important strategy for narrowing down on promising lead …

Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design

M Congreve, SP Andrews, AS Doré… - Journal of medicinal …, 2012 - ACS Publications
Potent, ligand efficient, selective, and orally efficacious 1, 2, 4-triazine derivatives have been
identified using structure based drug design approaches as antagonists of the adenosine …

The roles of water in the protein matrix: a largely untapped resource for drug discovery

F Spyrakis, MH Ahmed, AS Bayden… - Journal of medicinal …, 2017 - ACS Publications
The value of thoroughly understanding the thermodynamics specific to a drug
discovery/design study is well known. Over the past decade, the crucial roles of water …

Progress in structure based drug design for G protein-coupled receptors

M Congreve, CJ Langmead, JS Mason… - Journal of medicinal …, 2011 - ACS Publications
In 1998, Bikker, Trumpp-Kallmeyer, and Humblet published a Perspective in this journal
entitled “G-Protein Coupled Receptors: Models, Mutagenesis and Drug Design” and …

Predicting binding affinities for GPCR ligands using free-energy perturbation

EB Lenselink, J Louvel, AF Forti… - ACS …, 2016 - ACS Publications
The rapid growth of structural information for G-protein-coupled receptors (GPCRs) has led
to a greater understanding of their structure, function, selectivity, and ligand binding …

Molecular determinants of selectivity and efficacy at the dopamine D3 receptor

AH Newman, T Beuming, AK Banala… - Journal of medicinal …, 2012 - ACS Publications
The dopamine D3 receptor (D3R) has been implicated in substance abuse and other
neuropsychiatric disorders. The high sequence homology between the D3R and D2R …

Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines

KA Jacobson, ZG Gao, P Matricon… - British journal of …, 2022 - Wiley Online Library
A long evolution of knowledge of the psychostimulant caffeine led in the 1960s to another
purine natural product, adenosine and its A2A receptor. Adenosine is a short‐lived …

New insights from structural biology into the druggability of G protein-coupled receptors

JS Mason, A Bortolato, M Congreve… - Trends in pharmacological …, 2012 - cell.com
The recent availability of X-ray structures for diverse ligand-bound Family AG protein-
coupled receptors (GPCRs) in multiple conformations (inactive form with an …

Is it the shape of the cavity, or the shape of the water in the cavity?

PW Snyder, MR Lockett, DT Moustakas… - The European Physical …, 2014 - Springer
Historical interpretations of the thermodynamics characterizing biomolecular recognition
have marginalized the role of water. An important (even, perhaps, dominant) contribution to …